Filing Details

Accession Number:
0001209191-21-004992
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-22 20:59:47
Reporting Period:
2021-01-21
Accepted Time:
2021-01-22 20:59:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349376 P Timothy Walbert C/O Horizon Therapeutics Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-01-21 20,330 $0.00 966,889 No 4 M Direct
Ordinary Shares Disposition 2021-01-21 9,007 $77.43 957,882 No 4 F Direct
Ordinary Shares Disposition 2021-01-22 7,452 $76.25 950,430 No 4 S Direct
Ordinary Shares Disposition 2021-01-22 3,871 $76.90 946,559 No 4 S Direct
Ordinary Shares Acquisiton 2021-01-21 2,575 $0.00 14,563 No 4 M Indirect By spouse
Ordinary Shares Disposition 2021-01-21 755 $77.43 13,808 No 4 F Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect By spouse
No 4 F Indirect By spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2021-01-21 20,330 $0.00 20,330 $0.00
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2021-01-21 2,575 $0.00 2,575 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,336 No 4 M Direct
0 2021-01-21 2021-01-21 No 4 M Indirect
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.79 to $76.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.79 to $77.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Each PSU represents a contingent right to receive one ordinary share of the Issuer.
  5. The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022.